- China approved COVID-19 vaccinations for ages 3 to 17.
- Over 800 million vaccine doses have been administered across the country so far.
- The Sinopharm and Sinovac vaccines have been proven safe for the 3-17 age group.
- As of Thursday over 845.2 million doses of COVID-19 vaccines had been administered.
Chinese Center for Disease Control and Prevention on Friday reported that they have approved the emergency use of its domestic inactivated vaccines against COVID-19 on people aged from 3 to 17.
According to the Chinese Center for Disease Control and Prevention expert Shao Yiming, China’s mass-vaccination campaign currently targets adults aged over 18. He also mentioned that China’s mass-vaccination campaign so far has proved that its domestically-made vaccines are safe and effective.
The Sinopharm and Sinovac vaccines, both developed by China’s pharmaceutical institutions after clinical trials and expert reviews, have been proven safe for the 3-17 age group, and are now authorized for emergency use by the age group by related authorities.
Cui Gang, an official with the disease control department of China’s National Health Commission (NHC), mentioned that China will organize medical experts to formulate detailed policies on newly-granted vaccinations for people aged 3 to 17, and see that the effort is carried out in a safe and effective manner by the relevant authorities, said
According to the NHC, over 845.2 million doses of COVID-19 vaccines had been administered as of Thursday, with 622 million people vaccinated across China.